Recommendations from the independent Expert Advisory Group on the use of Paclitaxel Drug-Coated Balloons (DCBs) and Drug-Eluting Stents (DESs) to the MHRA
Posts published in “Medicines and Healthcare Products Regulatory Agency – MHRA”
Virtual manufacturing of medical devices.
Escopo da BSI para o MDR – Regulation (EU) 2017/745 on medical devices http://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=notification.pdf&dir_id=34&ntf_id=288798
MHRA response to EU exit no-deal legislative proposals consultation
After loosing the CE Mark and the ANSM recall – MHRA statement on Allergan
MHRA – Field safety notices – 03 to 07 December 2018. As a reminder, as part of Post Market Surveillance (PMS), manufacturers should track field…